Notice of Results

RNS Number : 7662G

Hutchison China Meditech Limited

08 February 2010

 



Hutchison China MediTech Limited ("Chi-Med")

(AIM: HCM)

Notice of Announcement of 2009 Final Results

London: Monday, 8 February 2010: Chi-Med will be announcing its final results for the year ended 31 December 2009 on Thursday, 4 March 2010.

Enquiries

Chi-Med Christian Hogg, CEO	Telephone: [phone]
Citigate Dewe Rogerson Anthony Carlisle David Dible	Telephone: [phone] [phone] [phone]
Lazard & Co., Ltd. Paul Gismondi Nick Fowler	Telephone: [phone]

About Chi-Med

Chi-Med is the holding company of a pharmaceutical and healthcare group based primarily in China and was admitted to trading on the Alternative Investment Market of the London Stock Exchange in May 2006. It is focused on researching, developing, manufacturing, and selling pharmaceuticals, health supplements and other consumer health and personal care products derived from Traditional Chinese Medicine and botanical ingredients.

Chi-Med is majority owned by Hutchison Whampoa Limited, an international company listed on the Main Board of The Stock Exchange of Hong Kong Limited.

 

END

 

 

NORKMGGZFKRGGZM